Dual Field PEMF Therapy in Lower Extremity Painful Diabetic Distal Symmetric Peripheral Neuropathy (RELIEF)
A Multi-Center, Double-Blind, Sham-Controlled, Randomized Trial of Dual Field PEMF Therapy [Provant® Therapy System] in Lower Extremity Painful Diabetic Distal Symmetric Peripheral Neuropathy (DSPN) (The RELIEF Trial)
Sponsor: Regenesis Biomedical, Inc.
Listed as NCT03455543, this NA trial focuses on Diabetic Neuropathy Peripheral and remains completed. Sponsored by Regenesis Biomedical, Inc., it has been updated 12 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Aug 2020 — Jan 2021 [monthly]
Completed NA
-
Apr 2020 — Aug 2020 [monthly]
Completed NA
▶ Show 7 earlier versions
-
Feb 2020 — Apr 2020 [monthly]
Completed NA
-
Oct 2019 — Feb 2020 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Oct 2018 — Oct 2019 [monthly]
Active Not Recruiting NA
-
Aug 2018 — Oct 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Recruiting NA
-
Apr 2018 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Mar 2018 — Apr 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Regenesis Biomedical, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .